In particular, an FGFR1 inhibitor, SU5402, reduced cell survival in MDA-MB-134 (overexpresses FGFR123), MCF7, and ZR-75-1 breast cancer cell lines and CAL51 metastatic breast cancer cell line24. This evidence concerns the gene FGFR1 and breast carcinoma.